Comparing two drugs for bleeding varices with kidney issues
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial compares two drugs, terlipressin and somatostatin, to see which better controls bleeding from varices in patients with cirrhosis who also have kidney problems. The goal is to find a treatment that improves outcomes for this serious situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with cirrhosis of the liver.
- You are currently having bleeding from enlarged veins in your esophagus or stomach (varices).
- You also have kidney problems (like abnormal kidney tests) at the time you join.
- You must not have a specific type of kidney failure called hepatorenal syndrome (HRS-AKI).
- You must not be on dialysis or have had a kidney transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches to prevent future bleeding from enlarged veins in the esophagus (food pipe) in patients with liver cirrhosis who have already had one bleeding episode. You'll receive either an endoscopic procedure with medication or a minimally invasive vein procedure, to see which works better long-term.
This trial compares a surgery called LSD with a procedure called TIPS to see which is better at preventing rebleeding in people with liver cirrhosis and an enlarged spleen. It may help if you have had bleeding from veins in your esophagus or stomach that came back after treatment.
This trial tests a slightly smaller TIPS stent (underdilated) against the standard size to see which is better at preventing another variceal bleed in people with cirrhosis and liver scarring. It aims to find the safest way to lower pressure in the veins while reducing side effects.
This trial tests whether adding metformin to carvedilol (a standard drug) lowers liver pressure more than carvedilol alone in people with cirrhosis who have had variceal bleeding. The goal is to prevent future bleeding.
This trial tests a procedure to lower blood loss during liver transplant for patients with high blood pressure in the liver. It may help those who have had a previous transplant, abdominal surgery, or certain complications of liver disease.
This trial compares giving terlipressin as a continuous infusion versus as a bolus for people with ACLF who have bleeding from varices in the esophagus. The goal is to see which method works better and is safer.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.